Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole
- 30 June 2012
- journal article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 39 (6), 500-504
- https://doi.org/10.1016/j.ijantimicag.2012.02.013
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experienceClinical Microbiology & Infection, 2011
- Anaerobic bacteria and antibiotics: What kind of unexpected resistance could I find in my laboratory tomorrow?Anaerobe, 2010
- Surveillance de la résistance aux antibiotiques des anaérobies stricts à Gram négatifMedecine Et Maladies Infectieuses, 2008
- European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocciInternational Journal of Antimicrobial Agents, 2008
- Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteriaInternational Journal of Antimicrobial Agents, 2006
- Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agentsJournal of Antimicrobial Chemotherapy, 2004
- In Vitro Activities of a New Des-Fluoro(6) Quinolone, Garenoxacin, against Clinical Anaerobic BacteriaAntimicrobial Agents and Chemotherapy, 2003
- Antibiotic resistance among anaerobic Gram-negative bacilli: lessons from a French multicentric surveyAnaerobe, 2003
- Survey of anaerobic susceptibility patterns: A French multicentre studyInternational Journal of Antimicrobial Agents, 1998
- Survey of the susceptibility patterns ofBacteroides fragilis group strains in France from 1977 to 1992European Journal of Clinical Microbiology & Infectious Diseases, 1992